State of Wisconsin Investment Board’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-5,700
Closed -$165K 1976
2020
Q2
$165K Hold
5,700
﹤0.01% 1617
2020
Q1
$275K Buy
5,700
+412
+8% +$24.9K ﹤0.01% 1518
2019
Q4
$301K Hold
5,288
﹤0.01% 1541
2019
Q3
$328K Hold
5,288
﹤0.01% 1435
2019
Q2
$238K Buy
5,288
+113
+2% +$5.66K ﹤0.01% 1470
2019
Q1
$325K Buy
5,175
+1,175
+29% +$70.6K ﹤0.01% 1412
2018
Q4
$216K Buy
4,000
+1,750
+78% +$128K ﹤0.01% 1447
2018
Q3
$226K Hold
2,250
﹤0.01% 1494
2018
Q2
$148K Hold
2,250
﹤0.01% 1443
2018
Q1
$112K Hold
2,250
﹤0.01% 1430
2017
Q4
$109K Hold
2,250
﹤0.01% 1420
2017
Q3
$137K Hold
2,250
﹤0.01% 1424
2017
Q2
$159K Buy
+2,250
New +$146K ﹤0.01% 1416

Other funds holding NERV

State of Wisconsin Investment Board's NERV Position: Q3 2020 in Review

State of Wisconsin Investment Board sold out of Minerva Neurosciences (NERV) in Q3 2020, closing a stake of 5,700 shares — an estimated $165K sold.

State of Wisconsin Investment Board first reported a position in NERV in Q2 2017 and held it in 13 quarters. The position peaked at $328K in Q3 2019. 76 funds tracked by Wall St. Rank hold NERV as of Q3 2020.

  • State of Wisconsin Investment Board reported no remaining Minerva Neurosciences position as of Q3 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 5,700 Minerva Neurosciences shares in Q3 2020, an estimated $165K.
  • State of Wisconsin Investment Board first reported a position in Minerva Neurosciences in Q2 2017 and held it in 13 quarters.
  • State of Wisconsin Investment Board's Minerva Neurosciences position peaked at $328K in Q3 2019.
  • 76 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2020, filed 16 Nov 2020.